ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 27 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 4.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,212,000 | +490.3% | 14,825,446 | +225.9% | 0.00% | – |
| Q1 2020 | $883,000 | -12.7% | 4,549,361 | -2.1% | 0.00% | – |
| Q4 2019 | $1,011,000 | -5.4% | 4,646,805 | 0.0% | 0.00% | – |
| Q3 2019 | $1,069,000 | +43.5% | 4,646,805 | +53.5% | 0.00% | – |
| Q2 2019 | $745,000 | -66.0% | 3,026,265 | -33.6% | 0.00% | – |
| Q1 2019 | $2,188,000 | +69.5% | 4,558,311 | +36.7% | 0.00% | – |
| Q4 2018 | $1,291,000 | -32.4% | 3,335,052 | +29.5% | 0.00% | – |
| Q3 2018 | $1,909,000 | +23.2% | 2,575,754 | +6.4% | 0.00% | – |
| Q2 2018 | $1,550,000 | +70.9% | 2,421,351 | -2.5% | 0.00% | – |
| Q1 2018 | $907,000 | -45.2% | 2,483,292 | -0.4% | 0.00% | – |
| Q4 2017 | $1,654,000 | +33.8% | 2,492,263 | +16.0% | 0.00% | – |
| Q3 2017 | $1,236,000 | -52.8% | 2,149,305 | +0.3% | 0.00% | – |
| Q2 2017 | $2,616,000 | -13.1% | 2,143,745 | +7.4% | 0.00% | – |
| Q1 2017 | $3,012,000 | +124.1% | 1,995,166 | +30.0% | 0.00% | – |
| Q4 2016 | $1,344,000 | -40.5% | 1,535,236 | -8.2% | 0.00% | – |
| Q3 2016 | $2,257,000 | -19.3% | 1,671,679 | +5.7% | 0.00% | – |
| Q2 2016 | $2,798,000 | +5.9% | 1,581,228 | +19.2% | 0.00% | – |
| Q1 2016 | $2,641,000 | -27.6% | 1,326,910 | +17.4% | 0.00% | – |
| Q4 2015 | $3,650,000 | -98.1% | 1,130,143 | -82.8% | 0.00% | -100.0% |
| Q3 2015 | $191,289,000 | +8559.5% | 6,574,244 | +688.8% | 0.01% | – |
| Q2 2015 | $2,209,000 | +15.5% | 833,425 | +7.6% | 0.00% | – |
| Q1 2015 | $1,913,000 | -38.9% | 774,718 | +45.9% | 0.00% | – |
| Q4 2014 | $3,129,000 | -8.9% | 531,170 | +3.7% | 0.00% | – |
| Q3 2014 | $3,433,000 | -1.5% | 512,403 | +6.2% | 0.00% | – |
| Q2 2014 | $3,484,000 | – | 482,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|